OvaScience Inc

Most Recent

  • uploads///Part  Graph
    Company & Industry Overviews

    IBB’s Top Performers: PETX Gains on Its First FDA Approval

    IBB’s top performers for March 21, 2016, were Cara Therapeutics (CARA), OvaScience (OVAS), Sarepta Therapeutics (SRPT), and Aratana Therapeutics (PETX).

    By Peter Neil
  • uploads///Part  Graph
    Company & Industry Overviews

    Bears Had the Upper Hand on February 29: IBB Lost 2.8%

    The bears had the last word in February as the markets ended the month in the red. The slowdown of the Chinese economy continued to weigh on markets as its manufacturing sector shrank for the seventh month in a row.

    By Peter Neil
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.